Abstract:Objective:Nutritional complications is an important prognosis factor for continuous ambulatory peritoneal dialysis (CAPD) patients. In this study, we investigated the short term effects of intraperitoneal amino acid solution in CAPD patients for six months. Methodology:Twenty-four CAPD patients were enrolled in this study, and randomly divided into the treatment group and the control group(12 in each). In the treatment group, during the day-time exchange of dialysate, each patient recieved a bag of dialysate(1.5% Dianeal) enriched with 100ml branch-chain amino acid. The control group, patients continued their CAPD with the same dialysate(1.5% Dianeal) as usual. All the patients were followed-up in this study for six months. Serum levels of albumin, transferrin, prealbumin were determined monthly. Nutritional parameters as nPNA(the normalized protein equivalent of nitrogen appearance), %LMB(percentage of lean body mass), MAMC(middle-arm muscle circumference) and TSF(triceps skinfold)were assessed during the study. Results:In the treatment group, serum level of albumin increased significantly as compared with the baseline level[(38.67±6.81)g/L vs (42.44±3.60)g/L, P0.05] after three months of treatment. Serum levels of transferrin[(2.74±0.37)g/L vs (2.93±0.16)g/L, P0.05] and prealbumin [(461.38±330.29)g/L vs (641.57±673.91)g/L,P0.05] were also found increased after three months of treatment and being stable thereafter. While in the control group, serum levels of transferrin [baseline vs 6-month:(2.51±0.47)g/L vs (2.41±0.53)g/L] and prealbumin [baseline vs 6-month: (450.12±286.31)g/L vs (351.58±172.36)g/L] declined singnificantly. Nutritional parameters as nPNA?%LBM and MAMC were stable throughout the study in the treatment group, while reduced singificantly in the control group (nPNA: 0.9612±0.13 vs 0.9426±0.17, P0.05; %LBM: 0.6849±0.02 vs 0.6452±0.04,P0.05) after the study. No significant difference in adequcy parameters of dialysis were found during the study. Triglycerides [baseline vs 6-month: (1.58±0.95)mmol/L vs (2.17±0.78)mmol/L,P0.05] and total cholesterol [baseline vs 6-month: (5.78±2.10)mmol/L vs (6.12±1.05)mmol/L,P0.05] increased significantly in the control group, while in the treatment group triglycerides decreased at the end of study[(1.66±0.94)mmol/L vs (1.52±0.56)mmol/L,P0.05]. No side effect and discomfirt complains were found in any patient of the treatment group during the dwelling of the amino acid enriched dialysate. Conclusion:Administration of amino acid enriched dialysate (1.5% dextrose) is a safe maneuver and a effective means to improve nutritional status in CAPD patients.

Remarkable improvement of activity by CAPD in a hemodialysis patient with a pseudotumor of the craniocervical junction

1.218 TWO CASES OF DURAL ARTERIOVENOUS FISTULA (DAVF) PRESENTING WITH PARKINSONISM AND PROGRESSIVE COGNITIVE DYSFUNCTION

CAPD in diabetics: use of aminoacids

The Treatment of Symptomatic Diffuse Proliferative Cerebral Angiopathy With Cilostazol: A Case Report

Destructive spondyloarthropathy mimicking spondylitis in long-term hemodialysis patients

Recovery of renal function in patients treated by CAPD

Continuous ambulatory peritoneal dialysis in AIDS patients with ESRD—Case report

Abdominal aortic calcification as prognostic marker in continuous ambulatory peritoneal dialysis

Hirayama disease successfully treated by posterior fixation: a case report

Combined effect of medical therapy and rehabilitation in Chronic Ataxic Neuropathy with anti-Disialosyl IgM Antibodies (CANDA): a case report

Effectiveness of Intravenous Cyclophosphamide in a Patient With Anti-amphiphysin Autoimmunity Presenting With Bulbar Palsy and Cerebellar Ataxia: A Case Report

Fluid status of CAPD patients at their early stage on dialysis

Peritoneal dialysis in the setting of acute brain injury: an underappreciated modality

Exploring the impact of cognitive impairments on treatment compliance and quality of life in patients with Continuous Ambulatory Peritoneal Dialysis (CAPD)

Editorial Commentary: Superior Capsular Reconstruction with Achilles Allograft Can Reverse Pseudoparalysis While Improving Functional Patient Outcomes

A Rare Case of Unilateral Adrenal Hyperplasia Accompanied by Hypokalaemic Periodic Paralysis Caused by a Novel Dominant Mutation in CACNA1S: Features and Prognosis after Adrenalectomy

Surgical treatment for dropped head syndrome with cervical spondylotic amyotrophy: a case report

A Short Term Study of Nutritional Effect of Intraperitoneal Amino Acid in CAPD Patients

Efficacy of Low-Dose Daytime Ambulatory Peritoneal Dialysis in Diabetic End-Stage Renal Disease Patients with Better Residual Renal Function

Effects of moderate physical activity on diabetic adhesive capsulitis: a randomized clinical trial

Long-term continuous ambulatory peritoneal dialysis in diabetics